Peter Francis Buckley
#90,410
Most Influential Person Now
Peter Francis Buckley's AcademicInfluence.com Rankings
Peter Francis Buckleyphilosophy Degrees
Philosophy
#3313
World Rank
#5380
Historical Rank
Logic
#1080
World Rank
#1718
Historical Rank
Download Badge
Philosophy Biology
Peter Francis Buckley's Degrees
- Doctorate Medicine University of Connecticut
- PhD Psychiatry University of Connecticut
Why Is Peter Francis Buckley Influential?
(Suggest an Edit or Addition)Peter Francis Buckley's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects (2011) (1402)
- Psychiatric comorbidities and schizophrenia. (2009) (943)
- Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk (2013) (724)
- Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths (2012) (722)
- Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine (1993) (406)
- Meta-Analysis of Oxidative Stress in Schizophrenia (2013) (384)
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) (361)
- The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. (2007) (287)
- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. (2020) (284)
- The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. (2004) (280)
- Negative symptoms of schizophrenia: a problem that will not go away (2007) (189)
- Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia (2009) (179)
- Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac? (2007) (177)
- Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals (2019) (176)
- Substance abuse in schizophrenia: a review. (1998) (176)
- Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique. (1998) (170)
- Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects (2013) (168)
- Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study (2009) (167)
- Clozapine‐induced weight gain associated with the 5HT2C receptor −759C/T polymorphism (2005) (164)
- Neurotrophins and schizophrenia (2007) (161)
- Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. (2009) (161)
- Brain derived neurotropic factor in first-episode psychosis (2007) (158)
- Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. (1994) (157)
- Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat StressBerton O, McClung CA, DiLeone RJ, et al (Univ of Texas Southwestern Med Ctr, Dallas; Tufts Univ School of Medicine, Boston) Science 311:864–868, 2006§ (2007) (155)
- 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates (1994) (153)
- Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. (2003) (151)
- Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. (2014) (146)
- Insight and its relationship to violent behavior in patients with schizophrenia. (2004) (138)
- Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder (2017) (136)
- When symptoms persist: clozapine augmentation strategies. (2001) (134)
- Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness. (2006) (129)
- Brain-derived neurotrophic factor: findings in schizophrenia (2011) (121)
- Prenatal inflammation and neurodevelopment in schizophrenia: A review of human studies (2013) (118)
- Clinicians' recognition of the metabolic adverse effects of antipsychotic medications (2005) (118)
- Lack of Insight in Schizophrenia (2007) (113)
- Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism (2009) (113)
- Treatment-Resistant Schizophrenia. (2007) (112)
- Biomarkers in Schizophrenia: A Brief Conceptual Consideration (2013) (110)
- Strategies for dosing and switching antipsychotics for optimal clinical management. (2008) (108)
- A systematic, quantitative review of blood autoantibodies in schizophrenia (2013) (106)
- Violence and schizophrenia: clozapine as a specific antiaggressive agent. (1995) (106)
- The role of typical and atypical antipsychotic medications in the management of agitation and aggression. (1999) (105)
- How connected are people with schizophrenia? Cell phone, computer, email, and social media use (2015) (105)
- Oral versus depot antipsychotic drugs for schizophrenia–A critical systematic review and meta-analysis of randomised long-term trials (2012) (102)
- Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics (2013) (100)
- Standard and Higher Dose of Olanzapine in Patients With Schizophrenia or Schizoaffective Disorder: A Randomized, Double-Blind, Fixed-Dose Study (2008) (100)
- Prevalence and consequences of dual diagnosis. (2006) (97)
- Exome sequencing identifies rare coding variants in 10 genes which confer substantial risk for schizophrenia (2020) (94)
- Association of Fkbp5 Polymorphisms and Childhood Abuse with Risk of Posttraumatic Stress Disorder Symptoms in Adults (2009) (94)
- Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer (2009) (93)
- Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications. (2007) (92)
- Psychotherapists view their personal therapy (1981) (92)
- Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: A meta-analysis (2015) (92)
- The Rupture and Repair of Cooperation in Borderline Personality Disorder (2009) (91)
- Looking on the Bright Side of Serotonin Transporter Gene Variation (2012) (85)
- The relationship of minor physical anomalies and other putative indices of developmental disturbance in schizophrenia to abnormalities of cerebral structure on magnetic resonance imaging (1995) (84)
- Genotype–Environment Interaction in Schizophrenia-Spectrum Disorder: Long-term Follow-up Study of Finnish Adoptees (2006) (82)
- Antecedents and Sequelae of Sudden Parental Death in Offspring and Surviving Caregivers (2009) (81)
- Plasma BDNF Levels Vary in Relation to Body Weight in Females (2012) (81)
- Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression (1995) (80)
- Treatment-refractory schizophrenia (2001) (77)
- Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study. (2015) (74)
- Mystical experience and schizophrenia. (1981) (73)
- Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. (2012) (72)
- Aggression and schizophrenia: efficacy of risperidone. (1997) (72)
- Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials (2004) (71)
- Essential papers on object relations (1986) (71)
- Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial (2013) (70)
- Using Virtual Patients to Teach Empathy: A Randomized Controlled Study to Enhance Medical Students’ Empathic Communication (2016) (70)
- TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia (2018) (69)
- Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: A controlled study (1993) (68)
- The Professional Experiences of Peer Specialists in the Georgia Mental Health Consumer Network (2015) (67)
- Broad therapeutic uses of atypical antipsychotic medications (2001) (66)
- Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry (2019) (65)
- Morphine Use after Combat Injury in Iraq and Post-Traumatic Stress Disorder (2011) (64)
- Catechol O-methyltransferase Val158Met Genotype and Neural Mechanisms Related to Affective Arousal and Regulation (2008) (63)
- Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults: A Systematic Review and Meta-Analysis (2013) (62)
- The genomic psychiatry cohort: Partners in discovery (2013) (61)
- Impaired plasmalogens in patients with schizophrenia (2012) (61)
- Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia (2012) (60)
- Catechol-O-Methyltransferase (COMT) Genotypes and Working Memory: Associations with Differing Cognitive Operations (2007) (60)
- An open-label, pilot trial of adjunctive tocilizumab in schizophrenia. (2016) (59)
- Latent structure of psychotic experiences in the general population (2012) (58)
- The neurodevelopmental basis of schizophrenia (1996) (58)
- An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. (2021) (58)
- Differential Effect of Quetiapine on Depressive Symptoms in Patients with Partially Responsive Schizophrenia (2003) (56)
- Advancing Paternal Age and Bipolar Disorder (2009) (56)
- Insight and schizophrenia. (2001) (56)
- Autoimmune Diseases and Severe Infections as Risk Factors for Schizophrenia: A 30-Year Population-Based Register Study (2013) (55)
- Cannabis, COMT and psychotic experiences (2013) (55)
- Association of Low Striatal Dopamine D2 Receptor Availability With Nicotine Dependence Similar to That Seen With Other Drugs of Abuse (2009) (55)
- Treatment of the psychotic patient who is violent. (2003) (55)
- Electroencephalographic Alpha Measures Predict Therapeutic Response to a Selective Serotonin Reuptake Inhibitor Antidepressant: Pre- and Post-Treatment Findings (2009) (53)
- Dose Response and Atypical Antipsychotics in Schizophrenia (2004) (53)
- Immersing Practitioners in the Recovery Model: An Educational Program Evaluation (2009) (53)
- Neuroprotection: A New Strategy in the Treatment of Schizophrenia (2007) (53)
- Meta-Analysis of Anti-Toxoplasma gondii IgM Antibodies in Acute Psychosis. (2014) (53)
- A randomized study of cognitive remediation for forensic and mental health patients with schizophrenia. (2015) (52)
- Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials (2010) (51)
- Insight into illness and attitudes toward medications among inpatients with schizophrenia. (2002) (51)
- Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses (2013) (50)
- A prevalence study of urinary tract infections in acute relapse of schizophrenia. (2013) (49)
- A three-dimensional morphometric study of craniofacial shape in schizophrenia. (2005) (49)
- Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study (2012) (48)
- Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia. (1998) (47)
- The Use of Simulation to Teach Suicide Risk Assessment to Health Profession Trainees—Rationale, Methodology, and a Proof of Concept Demonstration with a Virtual Patient (2015) (47)
- Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications (2005) (47)
- The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone (2007) (46)
- Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant Efficacy (2009) (45)
- Borderline Personality Disorder, Impulsivity, and the Orbitofrontal Cortex (2007) (45)
- Functional magnetic resonance imaging in schizophrenia: initial methodology and evaluation of the motor cortex (1997) (43)
- Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents. (2007) (42)
- The clinical stigmata of aberrant neurodevelopment in schizophrenia. (1998) (42)
- Magnetic resonance imaging of schizophrenia-like psychoses associated with cerebral trauma: clinicopathological correlates. (1993) (41)
- A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia. (2011) (41)
- Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: developmental origins and amelioration by antipsychotics? (1998) (40)
- The brief psychiatric rating scale: effect of scaling system on clinical response assessment. (1994) (38)
- Metabolic Syndrome Predisposes to Depressive Symptoms: A Population-Based 7-Year Follow-Up Study (2009) (38)
- Defining “good” and “poor” outcomes in patients with schizophrenia or schizoaffective disorder: A multidimensional data-driven approach (2009) (38)
- The Supervisory Situation (1998) (38)
- Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project (2009) (38)
- Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder: a randomized trial. (2015) (38)
- Psychopharmacology of aggression in schizophrenia. (2011) (38)
- Understanding and treating "first-episode" schizophrenia. (2007) (38)
- Neuroinflammation and Schizophrenia (2019) (37)
- Misattributions of agency in schizophrenia are based on imprecise predictions about the sensory consequences of one's actions (2011) (37)
- Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases (2018) (36)
- Abnormalities of Cerebral Structure in Schizophrenia on Magnetic Resonance Imaging: Interpretation in Relation to the Neurodevelopmental Hypothesis (1992) (36)
- Structural brain imaging in schizophrenia. (1998) (36)
- Optimizing Treatment of Schizophrenia Enhancing Affective/Cognitive and Depressive Functioning (2005) (35)
- Recovery and systems transformation for schizophrenia. (2007) (34)
- Peers and peer-led interventions for people with schizophrenia. (2012) (34)
- Substance abuse and clozapine treatment. (1994) (34)
- New Dimensions in the Pharmacologic Treatment of Schizophrenia and Related Psychoses (1997) (34)
- Treatment of schizophrenia: let's talk dollars and sense. (1998) (33)
- Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS Study (2011) (33)
- Reliable biomarkers and predictors of schizophrenia and its treatment. (2012) (32)
- The Case for Adjunctive Monoclonal Antibody Immunotherapy in Schizophrenia. (2016) (32)
- Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia (2004) (32)
- Three-dimensional magnetic resonance-based morphometrics and ventricular dysmorphology in schizophrenia (1999) (31)
- Sharing and Selling of Prescription Medications in a College Student Sample (2011) (30)
- Does a latent class underlie schizotypal personality disorder? Implications for schizophrenia. (2013) (30)
- Microdeletions of 3q29 Confer High Risk for Schizophrenia (2012) (30)
- Update on the Etiology and Treatment of Schizophrenia and Bipolar Disorder (2008) (29)
- Pharmacogenetics and schizophrenia. (2007) (29)
- Minor physical anomalies: potentially informative vestiges of fetal developmental disruptions in schizophrenia (2011) (29)
- Urinary tract infections in acute psychosis. (2014) (29)
- Large group influence for decreased drug use: findings from two contemporary religious sects. (1980) (29)
- Schizophrenia research: The problem of controls (1992) (28)
- Family-Focused Treatment for Adolescents With Bipolar Disorder: Results of a 2-Year Randomized Trial (2009) (28)
- Association Between Brain-Derived Neurotrophic Factor Val66met Gene Polymorphism and Progressive Brain Volume Changes in Schizophrenia (2009) (28)
- Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses (2015) (28)
- Schizophrenia and mood disorders : the new drug therapies in clinical practice (1999) (28)
- Sexuality and Serious Mental Illness (1999) (27)
- Increased prefrontal sulcal prominence in relatively young patients with unipolar major depression (1996) (27)
- State hospitals' responses to the sexual behavior of psychiatric inpatients. (1997) (26)
- Neuroleptic malignant syndrome. (1995) (26)
- The Age of Insight: The Quest to Understand the Unconscious in Art, Mind, and Brain, from Vienna 1900 to the Present (2012) (26)
- Stimulus sequence affects schizophrenia-normal differences in event processing during an auditory oddball task. (2005) (25)
- Genomewide Linkage Scan of 409 European-Ancestry and African American Families with Schizophrenia: Suggestive Evidence of Linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the Combined Sample (2007) (25)
- Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the Current Opioid Misuse Measure (COMM) (2012) (24)
- Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia (1995) (24)
- Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder (2009) (24)
- Prognostic value of polygenic risk scores for adults with psychosis (2021) (24)
- Insomnia and suicidal ideation in nonaffective psychosis (2018) (24)
- Taxometric analyses of paranoid and schizoid personality disorders (2012) (24)
- Magnetic resonance spectroscopy (2000) (24)
- Treating movement disorders and akathisia as side effects of antipsychotic pharmacotherapy. (2008) (24)
- Leadership Experiences and Characteristics of Chairs of Academic Departments of Psychiatry (2011) (23)
- Treatment of delusional disorders with clozapine [3] (1994) (23)
- Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapy. (2007) (23)
- Creativity and mental disorder: family study of 300 000 people with severe mental disorder (2013) (23)
- Comparative genomics of autism and schizophrenia (2011) (22)
- A content analysis of state hospital policies on sex between inpatients. (2000) (22)
- Sexual Behavior of Psychiatric Inpatients: Hospital Responses and Policy Formulation (1999) (22)
- “How to Speak to Your Psychiatrist”: Shared Decision-Making Training for Inpatients With Schizophrenia (2013) (22)
- A Cytogenetic Abnormality and Rare Coding Variants Identify ABCA13 as a Candidate Gene in Schizophrenia, Bipolar Disorder, and Depression (2011) (22)
- Update on the treatment and management of schizophrenia and bipolar disorder. (2008) (22)
- Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia. (2004) (22)
- Inflammation, Antipsychotic Drugs, and Evidence for Effectiveness of Anti-inflammatory Agents in Schizophrenia. (2019) (21)
- Pharmacotherapy for treatment-refractory schizophrenia (2011) (21)
- Dysfunctional Neural Plasticity in Patients With Schizophrenia (2009) (21)
- The involuntary nature of conversion disorder (2011) (21)
- 4. The age dependencies of MRI abnormalities in schizophrenia suggest early ventricular enlargement but later prominence of cortical atrophy (1991) (20)
- A Statewide Strategy for Expanding Graduate Medical Education by Establishing New Teaching Hospitals and Residency Programs (2015) (20)
- Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women With Psychosis: Results From the DAAMSEL Clinical Trial (2018) (20)
- A psychometric study of recovery among Certified Peer Specialists (2013) (19)
- New antipsychotic agents: emerging clinical profiles. (1999) (19)
- Treatment of schizoaffective disorder. (2009) (19)
- Adherence to mental health treatment (2009) (19)
- Resident Education and Perceptions of Recovery in Serious Mental Illness: Observations and Commentary (2007) (19)
- GWAS Significance Thresholds for Deep Phenotyping Studies Can Depend Upon Minor Allele Frequencies and Sample Size (2020) (19)
- A Functional Magnetic Resonance Imaging Study Of The Effects Of Low Frequency Right Prefrontal Transcranial Magnetic Stimulation In Depression (2009) (18)
- The art and science of switching antipsychotic medications, part 2. (2006) (18)
- Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study (2011) (18)
- Clinical and biochemical correlates of ‘high-dose’ clozapine therapy for treatment — refractory schizophrenia (2001) (18)
- Pharmacotherapy of delusional disorders in the context of offending and the potential for compulsory treatment. (2006) (18)
- Telomere length and early trauma in schizophrenia (2018) (17)
- Apolipoprotein E ε4 Allele Genotype and the Effect of Depressive Symptoms on the Risk of Dementia in Men: The Honolulu-Asia Aging Study (2009) (17)
- Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic. (2003) (17)
- Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine. (2007) (17)
- Brain structure and symptom dimension relationships in obsessive–compulsive disorder: A voxel-based morphometry study (2009) (17)
- First-Episode Psychosis: A Window of Opportunity for Best Practices (2007) (17)
- Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study (2017) (17)
- Green tea consumption is associated with depressive symptoms in the elderly (2011) (17)
- Recovery in Schizophrenia: What Consumers Know and Do Not Know. (2016) (16)
- Reflections on Leadership as Chair of a Department of Psychiatry (2006) (16)
- High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms: The ZEBRAS Study (2013) (16)
- A Western Diet Increases Serotonin Availability in Rat Small Intestine (2012) (16)
- Interaction of 5-HTTLPR and a Variation on the Oxytocin Receptor Gene Influences Negative Emotionality (2012) (16)
- Project GREAT: Immersing Physicians and Doctorally-Trained Psychologists in Recovery-Oriented Care (2014) (16)
- Violence and Schizophrenia — a study of the occurrence and clinical correlates of violence among schizophrenic patients (1990) (16)
- Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression (2011) (16)
- Schizophrenia Revealed. From Neurons to Social Interactions. (2002) (15)
- Monoclonal antibody immunotherapy in psychiatric disorders. (2017) (15)
- Schizophrenia in the Elderly (2000) (15)
- Factors that influence treatment success in schizophrenia. (2008) (15)
- Identifying schizophrenic patients who should not receive medication. (1982) (15)
- Rate of stimulation affects schizophrenia-normal differences on the N1 auditory-evoked potential (2004) (15)
- The current state and future possibilities of recruiting leaders of academic health centers. (2012) (15)
- Cannabis use and genetic predisposition for schizophrenia: a case-control study (2009) (15)
- Parental mental illness and fatal birth defects in a national birth cohort (2009) (14)
- Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to an N-Methyl-d-Aspartate Antagonist (2011) (14)
- Prenatal and Neonatal Brain Structure and White Matter Maturation in Children at High Risk for Schizophrenia (2012) (14)
- Predictors of Relapse in the Year After Hospital Discharge Among Patients With Schizophrenia (2013) (14)
- Altered gene expression in neural crest cells exposed to ethanol in vitro (2011) (14)
- Predicting relapse in schizophrenia: Is BDNF a plausible biological marker? (2017) (14)
- Association Study of 10 Genes Encoding Neurotrophic Factors and Their Receptors in Adult and Child Attention-Deficit/Hyperactivity Disorder (2009) (14)
- Evolving Concepts of the Pathogenesis of Irritable Bowel Syndrome: To Treat the Brain or the Gut? (2012) (14)
- The association between anomalous self-experience and suicidality in first-episode schizophrenia seems mediated by depression (2013) (14)
- Provision of Pain- and Symptom-Relieving Drugs for HIV/AIDS in Sub-Saharan Africa (2012) (14)
- Neuroimaging Schizophrenia: A Picture Is Worth a Thousand Words, but Is It Saying Anything Important? (2013) (13)
- Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study (2009) (13)
- If patients with schizophrenia have small brains, why don't they have small heads? (2000) (13)
- Dual Diagnosis of Substance Abuse and Severe Mental Illness: The Scope of the Problem (2007) (13)
- Obsessive–compulsive symptoms and clozapine (1994) (13)
- Mystical experience, spiritual knowledge, and a contemporary ecstatic religion. (1979) (13)
- Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder (2020) (13)
- Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians (2007) (13)
- NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis (2019) (13)
- Pharmacologic Treatments for Co-Occurring Substance Use Disorders in Patients with Schizophrenia (2005) (12)
- Clozapine treatment of schizophrenia: implications for forensic psychiatry. (1995) (12)
- New-age patient communications through social networks. (2011) (12)
- Paternal age effect: Replication in schizophrenia with intriguing dissociation between bipolar with and without psychosis (2016) (12)
- Treatment of delusional disorders with clozapine. (1994) (12)
- Schizophrenia and Substance Abuse Co-Morbidity (2005) (12)
- Altered Cell Cycle Dynamics in Schizophrenia (2013) (12)
- Risk of Neuroleptic Malignant Syndrome in Patients with Bipolar Disorder: A Retrospective, Population-Based Case-Control Study (2009) (12)
- Maintenance treatment for schizophrenia with quetiapine (2004) (12)
- Anesthetizing the Morbidly Obese Patient (1990) (11)
- Substance misuse treatment for high-risk chronic pain patients on opioid therapy: A randomized trial (2012) (11)
- Atypical neuroleptic malignant syndrome and atypical antipsychotics. (1998) (11)
- Olanzapine: a critical review of recent literature (2005) (11)
- In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or “Ecstasy”) and Hallucinogen Users (2012) (11)
- Schizophrenia, Sexuality, and Recovery (2012) (11)
- A Neglected Treatment (1986) (11)
- Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study (2009) (11)
- Psychotic depression: an underappreciated window to explore the dimensionality and pathobiology of psychosis. (2013) (11)
- Pain Documentation and Predictors of Analgesic Prescribing for Elderly Patients During Emergency Department Visits (2012) (11)
- Gender related differences in clinical characteristics and hospital based resource utilization among older adults with schizophrenia (2002) (11)
- Clinical and biochemical correlates of clozapine response in patients with comorbid substance abuse and schizophrenia (2000) (11)
- Methamphetamine Self-Administration Produces Attentional Set-Shifting Deficits and Alters Prefrontal Cortical Neurophysiology in Rats (2012) (11)
- Recovery in Schizophrenia: Perspectives, Evidence, and Implications (2011) (10)
- Stability of Psychiatric Outcomes of Low Birth Weight: A Longitudinal Investigation (2009) (10)
- Head size and schizophrenia (2002) (10)
- Parental type 2 diabetes in patients with non-affective psychosis (2016) (10)
- The Archaeology of Mind: Jaak Panksepp and Lucy Biven (2012) New York (2013) (10)
- Personalized medicine for schizophrenia (2017) (10)
- Treatment response in major depression: effects of personality dysfunction and prior depression (2011) (10)
- Electronic cigarette use in patients with schizophrenia: Prevalence and attitudes. (2017) (9)
- Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study. (2016) (9)
- Genetic analysis of deep phenotyping projects in common disorders (2017) (9)
- Regional- and Age-Dependent Reduction in trkB Receptor Expression in the Hippocampus Is Associated with Altered Spine Morphologies (2007) (9)
- The Medical School Dean: Leadership and Workforce Development (2014) (9)
- RECOVERY: International efforts at implementing and advancing the recovery model (2012) (9)
- Recovery and Schizophrenia (2007) (9)
- Brain Volumes in Relatives of Patients With Schizophrenia: A MetaanalysisBoos HBM, Aleman A, Cahn W, et al (Univ Med Ctr Utrecht, The Netherlands; Univ Med Ctr Groningen, The Netherlands) Arch Gen Psychiatry 64:297–304, 2007§ (2008) (9)
- Catching up on schizophrenia. The Fifth International Congress on Schizophrenia Research, Warm Springs, Va, April 8-12, 1995. (1996) (9)
- Self psychology, object relations theory and supportive psychotherapy. (1994) (9)
- Differential white blood cell counts may predict urinary tract infection in acute non-affective psychosis (2013) (9)
- Triumphs and challenges of transforming a state psychiatric hospital in Georgia (2013) (9)
- Current Management of Schizophrenia: Antipsychotic Monotherapy versus Combination Therapy. (2008) (9)
- A Double-Blind, Randomized Trial of Sertraline for Alcohol Dependence: Moderation by Age and 5-Hydroxytryptamine Transporter-Linked Promoter Region Genotype (2012) (9)
- Eicosapentaenoic Acid Interventions in Schizophrenia: Meta-Analysis of Randomized, Placebo-Controlled Studies (2013) (9)
- Treatment-refractory schizophrenia (2005) (9)
- Leadership development: more than on-the-job training (2009) (8)
- Using Computational Patients to Evaluate Illness Mechanisms in Schizophrenia (2012) (8)
- Wilson's disease and the neuroleptic malignant syndrome (1990) (8)
- Serotonin transporter and BDNF genetic variants interact to predict cognitive reactivity in healthy adults (2012) (8)
- Research Review: The neurobiology and genetics of maltreatment and adversity (2012) (8)
- Predicting the development of schizophrenia in high-risk populations: systematic review of the predictive validity of prodromal criteria (2013) (8)
- Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects (2011) (8)
- Novel antipsychotic agents and their implications for forensic psychiatry. (1999) (8)
- Clozapine and Risperidone: Refining and Extending Their Use (1996) (8)
- Assessing the Prevalence of Nonmedical Prescription Opioid Use in the General Canadian Population: Methodological Issues and Questions (2012) (8)
- Telephone versus face-to-face administration of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, for diagnosis of psychotic disorders (2013) (7)
- Leadership and professional workforce development. (2008) (7)
- Clinical Features Associated With Poor Pharmacologic Adherence in Bipolar Disorder: Results From the STEP-BD Study (2012) (7)
- Ziprasidone: pharmacology, clinical progress and therapeutic promise. (2000) (7)
- Treatment-Refractory Schizophrenia: A Clinical Conundrum (2014) (7)
- Personalized medicine for schizophrenia (2017) (7)
- Distinct Neural Correlates of Washing, Checking, and Hoarding Symptom Dimensions in Obsessive-Compulsive DisorderMataix-Cols D, Wooderson S, Lawrence N, et al (Inst of Psychiatry, London) Arch Gen Psychiatry 61:564–576, 2004§ (2006) (7)
- Increased Stress-Induced Dopamine Release in Psychosis (2013) (7)
- Fluoxetine Potentiates Methylphenidate-Induced Gene Regulation in Addiction-Related Brain Regions: Concerns for Use of Cognitive Enhancers? (2011) (7)
- Serotonergic Activity Influences the Cognitive Appraisal of Close Intimate Relationships in Healthy Adults (2012) (7)
- Informed consent and competency: doctor's dilemma on the consultation liaison service. (2007) (7)
- Early-emerging cognitive vulnerability to depression and the serotonin transporter promoter region polymorphism (2009) (7)
- A Web-Based Program to Empower Patients Who Have Schizophrenia to Discuss Quality of Care With Mental Health Providers (2013) (7)
- A Randomized, Controlled Trial With 6-Month Follow-Up of Repetitive Transcranial Magnetic Stimulation and Electroconvulsive Therapy for Severe Depression (2008) (7)
- Neuroleptic Malignant Syndrome — follow-up study (1991) (7)
- Psychotherapy and schizophrenia. (1996) (7)
- Increased Hippocampal Neurogenesis in Alzheimer's Disease (2006) (7)
- Quantitative levels of aripiprazole parent drug and metabolites in urine (2014) (7)
- Central Serotonin Transporter Availability Measured With [123I]β-CIT SPECT in Relation to Serotonin Transporter Genotypevan Dyck CH, Malison RT, Staley JK, et al (Yale Univ, New Haven, Conn; West Haven VA Med Ctr, Conn) Am J Psychiatry 161:525–531, 2004§ (2006) (7)
- Common variants of NRXN1, LRP1B and RORA are associated with increased ventricular volumes in psychosis - GWAS findings from the B-SNIP deep phenotyping study (2017) (7)
- Differential effects upon brain and serum BDNF levels in rats as response to continuous and intermittent administration strategies of two second generation antipsychotics (2013) (7)
- An open label study of quetiapine in patients with schizophrenia and alcohol disorders (2009) (7)
- Psychosis Susceptibility Gene ZNF804A and Cognitive Performance in Schizophrenia (2012) (7)
- A comorbid anxiety disorder does not result in an excess risk of death among patients with a depressive disorder (2013) (6)
- Magnetic resonance spectroscopy. Bridging the neurochemistry and neuroanatomy of schizophrenia. (2000) (6)
- The Medical Basis of Psychiatry, 3rd ed. (2010) (6)
- Self-perceived cognitive functioning does not correlate with objective measures of cognition in schizophrenia (2013) (6)
- Paradoxical reaction to fluoxetine. (2003) (6)
- Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole. (2005) (6)
- Variation in DISC1 affects hippocampal structure and function and increases risk for schizophreniaCallicott JH, Straub RE, Pezawas L, et al (NIH, Bethesda, Md) Proc Natl Acad Sci U S A 102:8627–8632, 2005§ (2007) (6)
- Erratum: Dose response and atypical antipsychotics in schizophrenia (CNS Drugs (2004) 18:9 (597-616)) (2004) (6)
- Is Relapse in Schizophrenia an Immune-Mediated Effect? (2012) (6)
- Novel Antipsychotics and Patient Care in State Hospitals (1998) (6)
- Back to Life, Back to Normality: Cognitive Therapy, Recovery, and Psychosis (2010) (6)
- Schizophrenia: current concepts and approaches to patient care. (2008) (6)
- Peer Specialists as Educators for Recovery-Based Systems Transformation (2012) (6)
- Emerging From the COVID Crisis With a Stronger Health Care Workforce (2020) (6)
- Cerebral asymmetry, planum temporale, and aberrant neurodevelopment in schizophrenia. (1994) (6)
- Effective Dosing and Dose Equivalency of Second-Generation Antipsychotic Medications (2004) (6)
- Parental age effects on odor sensitivity in healthy subjects and schizophrenia patients (2016) (6)
- Easy and Low-Cost Identification of Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotics: Artificial Neural Network and Logistic Regression Models (2011) (6)
- The care and feeding of chairs of departments of psychiatry. (2010) (6)
- Suicide in schizophrenia (1991) (6)
- Stress hormones in patients with posttraumatic stress disorder caused by myocardial infarction and role of comorbid depression (2011) (6)
- Magnetic resonance spectroscopy in Schizophrenia: A nascent technology for a neurodevelopmental dirorder? (1994) (6)
- Risperidone for Treatment-Resistant Schizophrenia: Initial Clinical Experience in a State Hospital (1996) (6)
- Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia (2013) (6)
- Implementing effectiveness research and improving care for schizophrenia in real-world settings. (1999) (6)
- Pharmacogenetics and schizophrenia. (2010) (6)
- Effects of omega-3 fatty acids on orexigenic and anorexigenic modulators at the onset of anorexia (2007) (6)
- Novel antipsychotics and neuroleptic malignant syndrome. (1996) (5)
- Aripiprazole and Dehydroaripiprazole Plasma Concentrations and Clinical Responses in Patients With Schizophrenia (2013) (5)
- Generic penetration in the retail atypical antipsychotic market. (2010) (5)
- Psychosis Following use of Proprietary Antidiarrhoeal Medicines (1990) (5)
- The art and science of switching of antipsychotic medications, part 1. (2006) (5)
- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. (2020) (5)
- Serotonin Transporter Polymorphism Moderates Effects of Prenatal Maternal Anxiety on Infant Negative Emotionality (2012) (5)
- Fifty years after Freud: Dora, the Rat Man, and the Wolf-Man. (1989) (5)
- Dosing equivalency of second-generation antipsychotic medications. (2005) (5)
- Sleep in schizophrenia: time for closer attention (2013) (5)
- Increased neural response to fear in patients recovered from depression: a 3T functional magnetic resonance imaging study (2011) (5)
- Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial (2017) (5)
- Pain relief in office gynaecology: a systematic review and meta-analysis (2012) (5)
- Vietnam's Palliative Care Initiative: Successes and Challenges in the First Five Years (2012) (5)
- Navigating Patient- and Family-Centered Care Rounds: A Guide to Achieving Success (2010) (5)
- Further exploration of the possible influence of polymorphisms in HTR2C and 5HTT on body weight (2012) (4)
- Insight in schizophrenia and risk of suicide: a systematic update (2013) (4)
- Essential papers on psychosis (1988) (4)
- Schizophrenia Spectrum and Other Psychotic Disorders: DSM-5 Selections (2016) (4)
- A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels (2021) (4)
- Erratum: Treatment of schizophrenia: Let's talk dollars and sense (American Journal of Managed Care (March 1998) 4 (369-383)) (1998) (4)
- Abuse of neuroleptic drugs. (1991) (4)
- Do patients with schizophrenia have smaller heads? (2000) (4)
- DRUG REPURPOSING AND EMERGING ADJUNCTIVE TREATMENTS FOR SCHIZOPHRENIA (2014) (4)
- Traumatic brain injury and bipolar psychosis in the Genomic Psychiatry Cohort (2016) (4)
- Assessment of Treatment Algorithms Including Amantadine, Metformin, and Zonisamide for the Prevention of Weight Gain With Olanzapine: A Randomized Controlled Open-Label Study (2013) (4)
- Comorbidities of Antisocial Personality Disorder (2020) (4)
- Clozapine and NMS (1993) (4)
- Schizophrenia Research: A Progress Report. (2015) (4)
- Neurosurgeons' perspectives on psychosurgery and neuroenhancement: a qualitative study at one center (2012) (4)
- Schizophrenia Treatment Challenges (2003) (4)
- Comprehensive disease management for schizophrenia. (2000) (4)
- Magnetic resonance imaging of the 'mind': Implications for psychiatry (1993) (4)
- The Evolving Clinical Profile of Atypical Antipsychotic Medications (2001) (4)
- Ancient templates: the classical origins of psychoanalysis. (2001) (4)
- Bleuler and the Neurobiology of Schizophrenia (2013) (3)
- Flourishing or floundering? Prevalence and correlates of anxiety and depression among a population-based sample of adult cancer survivors 6months after diagnosis (2013) (3)
- Superior temporal gyrus volume in antipsychotic-naive people at risk of psychosis (2011) (3)
- Psychometric relationships of insight in patients with schizophrenia who commits violent acts (2003) (3)
- MR IMAGING AND SPECTROSCOPY IN SCHIZOPHRENIA IN RELATION TO THE NEURODEVELOPMENTAL HYPOTHESIS (1992) (3)
- FEASIBILITY STUDY OF MULTI-SITE COGNITIVE REMEDIATION IN THE SCHIZOPHRENIA TRIALS NETWORK (CRSTN) (2010) (3)
- Neuroinflammation in Alzheimer's Disease and Major Depression (2011) (3)
- Schizophrenia Today: What Do We Know—and How Sure Are We? (2001) (3)
- State Hospital-University Collaborations: A 25-Year Follow-Up (2010) (3)
- Clinical News (2009) (3)
- Atypical antipsychotics and hyperglycemia: Analysis of 11,994 Ohio DMH subjects (2003) (3)
- The history of psychiatry from the patient's viewpoint. (1974) (3)
- PRINCIPLES AND PRACTICES OF MEDICATION MANAGEMENT FOR PEOPLE WITH SCHIZOPHRENIA Evolution within a Recovery-Based Framework of Care (2012) (3)
- Association of a Serotonin Transporter Polymorphism (5-HTTLPR) With Depression, Perceived Stress, and Norepinephrine in Patients With Coronary Disease: The Heart and Soul Study (2009) (3)
- Transient Estradiol Exposure during Middle Age in Ovariectomized Rats Exerts Lasting Effects on Cognitive Function and the Hippocampus (2011) (3)
- Brain-Derived Neurotrophic Factor Signaling Modulates Cocaine Induction of Reward-Associated Ultrasonic Vocalization in Rats (2011) (3)
- Pharmacogenetics of Schizophrenia: Bringing ‘Order to Chaos' in the Psychopharmacology of Schizophrenia? (2010) (3)
- Review tempers expectations for peer-led services but further studies are required (2014) (3)
- The ubiquitous symptoms of schizophrenia. (1976) (3)
- Introduction: the art and science of switching antipsychotic medications. (2007) (3)
- Schizophrenia Host Vulnerability and Risk of Metabolic Disturbances During Treatment with Antipsychotics (2008) (3)
- Comorbid Psychiatric Disorders in Schizophrenia: More than Just a Chance Co-occurrence (2015) (3)
- Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients (2013) (3)
- Brain-derived neurotrophic factor and cocaine addiction (2011) (3)
- Comorbidities of Psychopathy and Antisocial Personality Disorder: Prevalence and Implications (2008) (3)
- The role of adherence to medication in the effectiveness of long-term treatment of schizophrenia (2007) (3)
- Whole blood BDNF levels in healthy twins discordant for affective disorder: Association to life events and neuroticism (2009) (3)
- Comparative Evaluation of Serotonin Transporter Radioligands 11C-DASB and 11C-McN 5652 in Healthy HumansFrankle WG, Huang Y, Hwang D-R, et al (Columbia Univ, New York; New York State Psychiatric Inst) J Nucl Med 45:682–694, 2004§ (2006) (3)
- Academic leadership searches: evolving best practices (2010) (3)
- Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia (2014) (3)
- Life stress, 5-HTTLPR and mental disorder: findings from a 30-year longitudinal study (2012) (3)
- Anorexia nervosa in males (1991) (2)
- The psychiatry workforce pool is shrinking. What are we doing about it (2016) (2)
- Schizophrenia research: a progress report, summarizing proceedings of the 1999 International Congress on Schizophrenia Research. (2000) (2)
- A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia (2009) (2)
- Schizophrenia: Causes, course, and neurodevelopment (2003) (2)
- Biology of Schizophrenia: Is Treatment Refractoriness Synonymous with Severity of Illness [A.K.A. Is This a Drug Efficacy Problem or an Expression of Severe Illness?] (2014) (2)
- Pharmacogenetics and Treatment-Resistant Schizophrenia (2014) (2)
- Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis. (2007) (2)
- Functional and Dysfunctional Synaptic Plasticity in Prefrontal Cortex: Roles in Psychiatric Disorders (2011) (2)
- Developing and Implementing a Policy for Consensual Sex Between Inpatients (2013) (2)
- How effective are the second generation antipsychotics (1998) (2)
- Magnetic resonance spectroscopy in schizophrenia: a nascent technology for a neurodevelopmental disorder? (1994) (2)
- 1H magnetic resonance spectroscopy of frontal and temporal lobe metabolism in schizophrenia (1993) (2)
- Hippocampal Volume Change in Depression: Late- and Early-Onset Illness ComparedLloyd AJ, Ferrier IN, Barber R, et al (Univ of Newcastle, Newcastle upon Tyne, UK; Newcastle Gen Hosp, Newcastle upon Tyne, UK) Br J Psychiatry 184:488–495, 2004§ (2006) (2)
- Antipsychotic Polypharmacy in Schizophrenia: ‘Secret Sauce or Wild Abandon?’ (2013) (2)
- Cortical thickness, gray matter volume, and white matter anisotropy and diffusivity in schizophrenia (2013) (2)
- Choosing the Right Dose of the Atypical Antipsychotics: Art or Science? (2004) (2)
- Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample (2009) (2)
- Schizophrenia research: a biennium of progress. Proceedings from the Sixth International Congress on Schizophrenia Research. Colorado Springs, CO, April 12-16, 1997. (1998) (2)
- Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression (2008) (2)
- Pharmacological and physical treatments (2012) (2)
- Correlates of1H-magnetic resonance spectroscopy in schizophrenia (1994) (2)
- Obstetric complications and schizophrenia: Authors' reply (1993) (2)
- Excessive Brain Volume Loss Over Time in Cannabis-Using First-Episode Schizophrenia Patients (2009) (2)
- Prediction of Combined Symptomatic and Functional Outcome in Patients with Schizophrenia or Schizoaffective Disorder (2006) (2)
- Leadership Development for Future Medical School Deans: Outcomes of the AAMC Council of Deans Fellowship Program (2020) (2)
- Dr. Buckley Replies (1990) (2)
- Predictors of response to pharmacological treatments in bipolar disorder (2006) (2)
- Re: AIDS Knowledge and Sexual Behaviour in Patients with Schizophrenia (1996) (2)
- Research and Practice in Substance Abuse Comorbidity (2005) (2)
- Personal History and the Origins of Psychoanalytic Ideas (1999) (2)
- Evidence suggests complex links between violence and schizophrenia. Interview by Bridget M. Kuehn. (2012) (2)
- P.2.014 Medication specific correlates of relapse risk in schizophrenia (2004) (2)
- Risperidone treatment of schizophrenia in a state hospital (1995) (2)
- Aripiprazole: an appraisal of the translation of complex receptor effects into clinical outcomes (2005) (2)
- 568 The safety and tolerability of sertindole in elderly patients with dementia (1997) (2)
- Pharmacogenetic Approach at the Serotonin Transporter Gene as a Method of Reducing the Severity of Alcohol Drinking (2012) (2)
- Prioritizing Harm (2017) (2)
- Impact of Scribe Experience on Undergraduate Medical Education (2020) (2)
- Brain-derived neurotrophic factor and neurocognitive profiles in the psychosis spectrum: Findings in bipolar disorder and schizophrenia (2013) (2)
- New therapeutic strategies for resistance to clozapine and treatment-resistant schizophrenia (2010) (2)
- Substance use comorbidity in patients with schizophrenia (2013) (2)
- Anterior Cingulum Abnormalities in Male Patients With Schizophrenia Determined Through Diffusion Tensor ImagingWang F, Sun Z, Cui L, et al (Peking Univ, Beijing, China) Am J Psychiatry 16:573–575, 2004§ (2006) (1)
- Schizophrenia: Contemporary clinical perspectives (2003) (1)
- A Randomized, Placebo-Controlled Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain (2013) (1)
- Hippocampal N-Acetylaspartate Concentration and Response to Riluzole in Generalized Anxiety Disorder (2009) (1)
- Editor's Pen (2009) (1)
- Genetics of Schizophrenia and Bipolar Disorder: Potential Clinical Applications (2021) (1)
- Alteration in Estrogen Receptor α mRNA Levels in Frontal Cortex and Hippocampus of Patients with Major Mental IllnessPerlman WR, Tomaskovic-Crook E, Montague DM, et al (NIH, Bethesda, Md; Uniformed Services Univ of Health Sciences, Bethesda, Md) Biol Psychiatry 58:812–824, 2005§ (2007) (1)
- ‘High dose’ clozapine therapy: Clinical and biochemical correlates (1996) (1)
- De fi ning “ good ” and “ poor ” outcomes in patients with schizophrenia or schizoaffective disorder : A multidimensional data-driven approach ☆ (2016) (1)
- The History of the American Association of Chairs of Departments of Psychiatry (2007) (1)
- A Cross-Sectional Evaluation of the Effect of Risperidone and Selective Serotonin Reuptake Inhibitors on Bone Mineral Density in Boys (2011) (1)
- Schizophrenia and paranoid psychoses (2009) (1)
- A Return to Innocence: Philosophical Guidance in an Age of Cynicism (1998) (1)
- Apoptotic Proteins in the Temporal Cortex in Schizophrenia: High Bax/Bcl-2 Ratio Without Caspase-3 ActivationJarskog LF, Selinger ES, Lieberman JA, et al (Univ of North Carolina, Chapel Hill) Am J Psychiatry 161:109–115, 2004§ (2006) (1)
- Polygenic risk scores lack prognostic value for adults with severe mental illness (2021) (1)
- Resilience and Being Thankful (2020) (1)
- Functional magnetic resonance imaging of the motor cortex in schizophrenia: Procedures and initial observations (1995) (1)
- Self-stigma and its relationship with insight, demoralization, and clinical outcome among people with schizophrenia spectrum disorders (2013) (1)
- Managed care in public mental health systems: The Ohio initiative (1999) (1)
- Subjective Experience of Cognitive Failures as Possible Risk Factor for Negative Symptoms of Psychosis in the General Population (2011) (1)
- Medical and Psychiatric Comorbidities: Complicating Treatment Expectations (2014) (1)
- Clinical, Functional, and Intertask Correlations of Measures Developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium (2013) (1)
- Affective Impairment in Schizophrenia: Depression/Anxiety (2005) (1)
- 16 Sexuality and schizophrenia: Behavioral patterns and clinical correlates (1997) (1)
- This issue: Comorbidities in Schizophrenia: Clinical Management and Conceptual Issues (2013) (1)
- First episode schizophrenia: Considerations on the timing, selection, and duration of antipsychotic therapies (2009) (1)
- 13th National Congress of the South African Society of Psychiatrists, 20-23 September 2004 (2004) (1)
- Schizophrenia: Current Science and Clinical Practice (2012) (1)
- Clinical Schizophrenia & Related Psychoses' (CS) fifth year of publication. (2012) (1)
- Plasma levels and dosing strategies in schizophrenic patients receiving clozapine (1995) (1)
- The boundaries of schizophrenia: Overlap with bipolar disorders (2004) (1)
- Clozapine and aggression: Specificity of treatment response? (1995) (1)
- Georgia's innovative response to GME expansion. (2015) (1)
- An object relations perspective on the nature of resistance and therapeutic change. (1996) (1)
- International Medical Graduates in the United States Psychiatry Workforce (2022) (1)
- Clozapine plasma levels and dosing strategies in patients with treatment-refractory schizophrenia (1997) (1)
- Applications of Individual Supportive Psychotherapy to Psychiatric Disorders: Efficacy and Indications (2008) (1)
- Psychoanalysis and Its Romantic Rebellion (1997) (1)
- The Nature of Traumatic Memories: A 4-T fMRI Functional Connectivity AnalysisLanius RA, Williamson PC, Densmore M, et al (Univ of Western Ontario, London, Canada) Am J Psychiatry 161:36–44, 2004§ (2006) (1)
- Principles of treatment for the mentally disordered offender (2014) (1)
- Chapter 4 Epidemiology and longitudinal course (2008) (1)
- Treatment-Resistant Schizophrenia. (2020) (1)
- New uses for new antipsychotics (2000) (1)
- National Trends in Psychotherapy by Office-Based Psychiatrists (2009) (1)
- Developmental precursors of tardive dyskinesia in schizophrenia: Minor physical anomalies, frontal lobe dysfunction and cerebral structure on MRI (1995) (1)
- SU5. Investigation of the Visual Steady-State Response in Schizophrenia, Schizoaffective, Psychotic, and Nonpsychotic Bipolar Disorders. (2017) (1)
- Physical Health and Schizophrenia (2017) (1)
- Generative and Generous (2021) (1)
- Role of serotonin in forensic psychiatry. (1996) (1)
- Nerve growth factor in never-medicated first episode psychotic and medicated-schizophrenic patients: Possible implications for treatment outcome (2003) (1)
- 80. Meta-analysis of monocytes and lymphocytes in schizophrenia: Clinical status and antipsychotic effects (2012) (1)
- Where we practice: Augusta. (2016) (1)
- Gender Differences in Risk Factors for Aberrant Prescription Opioid Use (2011) (1)
- Medicolegal Considerations in the Treatment of Psychosis With Second-Generation Antipsychotics (2004) (1)
- The Association Between Major Depression and Levels of Soluble Intercellular Adhesion Molecule 1, Interleukin-6, and C-Reactive Protein in Patients With Recent Acute Coronary SyndromesLespérance F, Frasure-Smith N, Théroux P, et al (l'Université Montréal; McGill Univ, Montreal; Hôpital du Sacré-Coeu (2006) (1)
- 207. Magnetic resonance spectroscopy and aberrant (1998) (1)
- Comorbidity and Schizophrenia (2018) (1)
- From the Editor's Pen (2008) (1)
- 405 Prediction of intracranial volume from post-mortem head, stature and body frame measurements: Influences of gender, race, and implications for schizophrenia research (1997) (1)
- Minor physical anomalies, other indices of developmental disruption in schizophrenia, and cerebral asymmetry on MRI (1993) (1)
- Diagnosis and classification (2012) (1)
- Continuous Sciatic Nerve Blocks (1992) (1)
- Chronic Treatment with Mood Stabilizers Lithium and Valproate Prevents Excitotoxicity by Inhibiting Oxidative Stress in Rat Cerebral Cortical CellsShao L, Young LT, Wang J-F (Univ of Toronto) Biol Psychiatry 58:879–884, 2005§ (2007) (1)
- Turnover of First-Time Chairs in Departments of Psychiatry (2011) (1)
- Rheumatoid Arthritis Drugs for Schizophrenia (2018) (1)
- A Propitious Moment in the Midst of Crisis: A Case Study of Organizational Change in an Academic Department (2011) (1)
- Risperidone prevents and restores haloperidol-induced oxidative stress-mediated brain injury (2003) (1)
- Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study (2013) (1)
- Improvement in cognitive functions and psychopathology in treatment-refactory schizophrenic patients receiving clozapine (1993) (1)
- Olanzapine vs. lithium in management of acute mania (2011) (1)
- FROM THE EDITOR'S PEN (2008) (0)
- Converging Perspectives on Schizophrenia. (2016) (0)
- Nutritional and OTC Supplements in Schizophrenia: What Role? (Video 2:53 minutes) (2012) (0)
- Chapter 7 Models of care (2008) (0)
- The Neurobiological "Melting Pot" of Psychiatric Diagnoses. (2018) (0)
- DEFICITS IN BRAIN DERIVED NEUROTROPHIC FACTORS: POTENTIAL AS AN EARLY-PHASE BIOMARKER FOR SCHIZOPHRENIA? (2010) (0)
- Neural Response to Emotional Prosody in Schizophrenia and in Bipolar Affective DisorderMitchell RLC, Elliott R, Barry M, et al (Univ of Reading, London; Univ of Manchester, UK; Univ of Sheffield, UK) Br J Psychiatry 184:223–230, 2004§ (2006) (0)
- A Randomized, Placebo-Controlled Trial of OROS Methyphenidate in Adults with Attention-Deficit/Hyperactivity Disorder (2007) (0)
- Editor's Pen (2009) (0)
- 2013 Wayne Fenton Award for Exceptional Clinical Care (2013) (0)
- Preventing breast cancer in women with schizophrenia (2012) (0)
- 0167 DEFICITS IN BRAIN DERIVED NEUROTROPHIC FACTOR AT THE ONSET OF SCHIZOPHRENIA (2006) (0)
- Models of care (2012) (0)
- Chapter 10 Special clinical situations (2008) (0)
- Dual Diagnosis: A Challenge for ED Clinicians (2006) (0)
- Gene Knockout of Glycine Transporter 1: Characterization of the Behavioral PhenotypeTsai G, Ralph-Williams RJ, Martina M, et al (McLean Hosp, Belmont, Mass; Ottawa Health Research Inst, Ont, Canada; Wellesley College, Mass) Proc Natl Acad Sci USA 101:8485–8490, 2004§ (2006) (0)
- Clinical News. (2016) (0)
- Psychotherapy's second century (1995) (0)
- post hoc analysis of pooled data from short-and long-term aripiprazole trials Evaluation of akathisia in patients with schizophrenia , schizoaffective disorder , or bipolar I disorder : a (2010) (0)
- Prospective Assessment of Transient Cocaine-Induced Psychotic Symptoms in a Clinical Setting (2013) (0)
- Clinical News. (2018) (0)
- Phenomenology of psychotic mood disorders: Lifetime and major depressive episode features (2013) (0)
- Clinical News. (2016) (0)
- Reply (2008) (0)
- Rate of stimulation a¡ects schizophrenia-normal di¡erences on the N1 auditory-evoked potential (2004) (0)
- Getting a Great Job: Preparing and “Wowing” at the Interview (2010) (0)
- The Psychiatric Interview Today (2016) (0)
- Influences of age and gender on cerebral morphology on computed tomography in schizophrenia (1993) (0)
- 25-Hydroxyvitamin D and metabolic-related laboratory values in women with schizophrenia and hyperprolactinemia. (2022) (0)
- Dizziness, migrainous vertigo and psychiatric disorders (2011) (0)
- Multicenter Study of Brain Volume Abnormalities in Children and Adolescent-Onset Psychosis (2013) (0)
- Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial (2013) (0)
- Psychological and psychosocial treatments (2012) (0)
- Unresponsive and mute after he smoked 'spice': Mr. r, age 19, who has no psychiatric history, experiences new-onset catatonia after ingesting a synthetic cannabinoid with the street name 'spice.' How would you care for him? (2016) (0)
- GHSU: addressing the state's physician shortage. (2011) (0)
- Dose Decrease and Other Correlates of Relapse in Patients with Schizophrenia or Schizoaffective Disorder During Olanzapine Drug Therapy (2006) (0)
- Correction to: Impact of Scribe Experience on Undergraduate Medical Education (2020) (0)
- Chapter 3 Comorbidity (2008) (0)
- What's New in Schizophrenia? (2012) (0)
- Schizophrenia and Other Psychotic Disorders (2013) (0)
- New name, school still addressing physician shortages in Georgia. (2011) (0)
- Developing Our Workforce and Advancing Collaborative Care. (2017) (0)
- Editor's Pen (2010) (0)
- 5-HT 2 A RECEPTOR BLOCKADE BY QUETIAPINE IS RELATED TO ITS SIDE EFFECT PROFILE (2000) (0)
- Preclinical Pharmacology of FMPD [6-Fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: A Potential Novel Antipsychotic with Lower Histamine H1 Receptor Affinity Than OlanzapineRasmussen K, Benvenga MJ, Bymaster FP, et al (Eli Lilly & Co, Indianapoli (2007) (0)
- 404 A study of head size in adult patients with schizophrenia (1997) (0)
- The Pathophysiology of Schizophrenia Disorders: Perspectives From the SpectrumSiever LJ, Davis KL (Mount Sinai School of Medicine, New York; Bronx VA Med Ctr, NY; VISN 3 Mental Illness Research, Education, and Clinical Ctr, Bronx, NY) Am J Psychiatry 161:398–413, 2004§ (2006) (0)
- Clinical News (2009) (0)
- ANNOUNCEMENT (2008) (0)
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial (2009) (0)
- Welcome to the April '12 issue of Clinical Schizophrenia and Related Psychoses (CS). Introduction. (2012) (0)
- Cerebral Glucose Metabolism in Obsessive-Compulsive Hoarding (2006) (0)
- 175.3 Inflammation, Substance use, Symptoms, and Cognition in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study (2017) (0)
- Treating Schizophrenia, One Symptom at a Time: Is it Feasible?(Video: 1:40 minutes) (2012) (0)
- Pharmacokinetic and Pharmacodynamic Interaction of Lorazepam and Valproic Acid in Relation to UGT2B7 Genetic Polymorphism in Healthy Subjects (2009) (0)
- Transference and the nature of psychotherapeutic change (1997) (0)
- Biomarkers, Personalized Medicine, and Schizophrenia (2016) (0)
- References and further reading (2008) (0)
- Q&A: On Early Diagnosis of Schizophrenia (2012) (0)
- Prescription Pain Medication Dependence (2012) (0)
- Comprar Schizophrenia, An Issue of Psychiatric Clinics | Peter F. Buckley | 9781416051169 | Saunders (2007) (0)
- Interactive Effects of DAOA (G72) and Catechol-O-Methyltransferase on Neurophysiology in Prefrontal Cortex (2012) (0)
- Ketamine Produces Lasting Disruptions in Encoding of Sensory StimuliMaxwell CR, Ehrlichman RS, Liang Y, et al (Univ of Pennsylvania, Philadelphia; Rider Univ, Lawrenceville, NJ) J Pharmacol Exp Ther 316:315–324, 2006§ (2007) (0)
- Sexual behavior among inpatients with schizophrenia (1998) (0)
- Organic psychosis (2020) (0)
- FROM THE EDITOR'S PEN (2007) (0)
- Chapter 9 Psychological and psychosocial treatments (2008) (0)
- How Should the Data Be Translated Into Clinical Practice ? (2006) (0)
- Longitudinal study of inflammation and relapse in schizophrenia (2023) (0)
- Evidence for Reduced Cerebellar Volumes in Trichotillomania (2008) (0)
- Stress Disorders: Patient Assessment and Management (2006) (0)
- Clinical News: New treatments under development, stigma, genetics and nosology, genetic counseling coming of age (2013) (0)
- Weight Gain in Schizophrenia: Tips for Prevention and Management (Video: 2:37 minutes) (2012) (0)
- Concordance between chart review and structured interview assessments of schizophrenic symptoms (2013) (0)
- Schizophrenia as a brain disease (2012) (0)
- Clinical News: New drug updates, DSM-5, brain initiative, urinary tract infections, prodromal research, stigma and global outreach … (2013) (0)
- Schizophrenia Q&A: Depot medications in schizophrenia therapy (Video 4:24 minutes) (2012) (0)
- Longitudinal course of obsessive-compulsive disorder in patients with anxiety disorders: a 15-year prospective follow-up study (2013) (0)
- Aripiprazole Blocks Reinstatement of Cocaine Seeking in an Animal Model of RelapseFeltenstein MW, Altar CA, See RE (Med Univ of South Carolina, Charleston; Psychiatric Genomics, Inc (CAA), Gaithersburg, Md) Biol Psychiatry 61:582–590, 2007§ (2008) (0)
- SCHIZOPHRENIA: FROM NEUROSCIENCE TO CLINICAL EXPERIENCE (2005) (0)
- Research and Practice in Substance Abuse Comorbidity (2005) (0)
- No Association Between the Putative Functional ZDHHC8 Single Nucleotide Polymorphism rs175174 and Schizophrenia in Large European Samples (2007) (0)
- Morphology of the Anterior Cingulate Gyrus in Patients With Schizophrenia: Relationship to Typical Neuroleptic ExposureKopelman A, Andreasen NC, Nopoulos P (Univ of Iowa, Iowa City; Univ of New Mexico, Albuquerque) Am J Psychiatry 162:1872–1878, 2005§ (2007) (0)
- Genetic and obstetrical determinants of cerebral morphology on computed tomography in schizophrenia (1993) (0)
- S79. HEALTH STATUS OF PREMENOPAUSAL WOMEN WITH SCHIZOPHRENIA HAVING HYPERPROLACTINEMIA (2019) (0)
- NEW DIAGNOSTIC SCALE FOR BIPOLAR DISORDER (2005) (0)
- Cerebral atrophy, signal hyperintensities and ventricular volume in schizophrenia on MRI: Relationship to the presence or absence of tardive dyskinesia (1991) (0)
- Probability of Obsessive and Compulsive Symptoms in Huntington's DiseaseBeglinger LJ, Langbehn DR, Duff K, et al (Univ of Iowa, Iowa City; Univ of Maryland, College Park) Biol Psychiatry 61:415–418, 2007§ (2008) (0)
- Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. (2022) (0)
- Are Gold Standard Depression Measures Appropriate for Use in Geriatric Cancer Patients? A Systematic Evaluation of Self-Report Depression Instruments Used With Geriatric, Cancer, and Geriatric Cancer Samples (2011) (0)
- FROM ACUTE TO MAINTENANCE: STRATEGIES IN THE TREATMENT OF BIPOLAR DISORDER (2004) (0)
- Brain imaging of schizophrenia: Findings suggestive of a neurological disorder (1997) (0)
- FROM THE EDITOR'S PEN (2007) (0)
- Effect of Subthalamic Nucleus Stimulation on Obsessive–Compulsive Disorder in a Patient With Parkinson Disease: Case ReportFontaine D, Mattei V, Borg M, et al (Universitaire de Nice, France) J Neurosurg 100:1084–1086, 2004§ (2006) (0)
- Schizophrenia: Advances and Current Management (2016) (0)
- Clinical News. (2018) (0)
- Medical College of Georgia at GRU. (2015) (0)
- Addressing Challenges and Opportunities for Better Outcomes (2003) (0)
- Copy Number Variation in Schizophrenia in the Japanese Population (2011) (0)
- Clinical News. (2018) (0)
- Research and Practice in Substance Abuse Comorbidity (2006) (0)
- Faculty Opinions recommendation of Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. (2009) (0)
- Inaugural national scientific medical meeting (1993) (0)
- Neurobiological Factors Linking Personality Traits and Major Depression (2009) (0)
- Progress in Schizophrenia Research and Treatment. (2020) (0)
- Erratum: New dimension in the pharmacologic treatment of schizophrenia and related psychoses (Journal of Clinical Pharmacology (1997) 37 (363-378)) (1998) (0)
- Partnering With Families. (2016) (0)
- Metabolome in schizophrenia and other psychotic disorders: a general population-based study (2012) (0)
- Introduction: Convergence of Thought? (2019) (0)
- SUPPLEMENT An expert review of clinical challenges in psychiatry Impact of Schizophrenia and Bipolar Disorder on the Affected Populations (2007) (0)
- Functional psychoses is the concept disintegrating? (1993) (0)
- National Trends in the Antipsychotic Treatment of Psychiatric Outpatients With Anxiety Disorders (2013) (0)
- Relationship of symptomatic remission with quality of life and functionality in patients with schizophrenia (2013) (0)
- Schizo-Obsessive Disorder (2014) (0)
- Chapter 1 Diagnosis and classification (2008) (0)
- What's It Worth? Public Willingness to Pay to Avoid Mental Illnesses Compared With General Medical Illnesses (2013) (0)
- Is Traumatic Brain Injury A Risk Factor for Schizophrenia? A Meta-Analysis of Case-Controlled Population-Based Studies (2013) (0)
- MRI morphometrics and volumetric analyses of cerebral morphology in schizophrenia (1998) (0)
- Poster #T208 PROACTIVE: EXPLORING LONGITUDINAL SYMPTOM COURSE TO UNDERSTAND OUTCOMES IN LAI-ORAL COMPARISONS (2014) (0)
- Craniofacial dysmorphology in schizophrenia: Midline deformation from morphometrics with 3-D facial holography (2003) (0)
- Early diagnosis and intervention in schizophrenia. (2012) (0)
- Clinical News. (2017) (0)
- Erratum: Aripiprazole: An appraisal of the translation of complex receptor effects into clinical outcomes (Therapy (2005) vol. 2 (3) (669-707)) (2006) (0)
- Computational Constraints on Syntactic Processing in a Nonhuman PrimateFitch WT, Hauser MD (Univ of St Andrews, Scotland; Harvard Univ, Cambridge, Mass) Science 303:377–380, 2004§ (2006) (0)
- Innovative Add-On Treatments for Schizophrenia (2018) (0)
- Extensive Genotyping of the BDNF and NTRK2 Genes Define Protective Haplotypes Against Obsessive-Compulsive Disorder (2009) (0)
- F88. CHILDHOOD SEXUAL ABUSE AND ADULT SEXUAL BEHAVIOR IN WOMEN WITH ANTIPSYCHOTIC-INDUCED HYPERPROLACTINEMIA (2019) (0)
- No association between the serotonin transporter gene polymorphism 5-HTTLPR and cyclothymic temperament as measured by TEMPS-A (2012) (0)
- Prolonged T2 relaxation time in schizophrenia and its relationship to lateral ventricular volume on MRI (1992) (0)
- Information for patients and carers (2008) (0)
- Psychiatric Genetics: A Survey of Psychiatrists' Knowledge, Opinions, and Practice PatternsFinn CT, Wilcox MA, Korf BR, et al (Massachusetts Gen Hosp, Boston; Boston Univ; Univ of Alabama at Birmingham; et al) J Clin Psychiatry 66:821–830, 2005§ (2007) (0)
- Update on putative novel antipsychotics. (2014) (0)
- The Metabolic Syndrome Is Associated with Reduced Central Serotonergic Responsivity in Healthy Community Volunteers (2008) (0)
- 60. Craving reduction and clozapine response in patients with comorbid substance abuse and schizophrenia (2000) (0)
- Alcohol and Aldehyde Dehydrogenase Polymorphisms in Men With Type 1 and Type II Alcoholism (2007) (0)
- Dr. Buckley and Colleagues Reply (2005) (0)
- Akathisia in schizophrenia patients treated with aripiprazole, haloperidol, or olanzapine - analysis of three double-blind, long-term trials (2007) (0)
- Disrupting the prefrontal cortex diminishes the human ability to build a good reputation (2011) (0)
- Auditory Hallucinations in Dissociative Identity Disorder and Schizophrenia With and Without a Childhood Trauma History: Similarities and Differences (2011) (0)
- A Pilot Study of Cranial Electrotherapy Stimulation for Generalized Anxiety Disorder (2009) (0)
- 390 Shape deformity in schizophrenia: A MRI morphometric study (1997) (0)
- new antipsychotics ... autism and schizophrenia ... genetic and other biomarkers ... auditory cortex morphology in schizophrenia ... phenotyping through drug and nonpharmacologic response ... treatment-refractory schizophrenia ... smartphones ... (2017) (0)
- Antipsychotics activate the TGFβ pathway effector SMAD3 (2013) (0)
- Clinical news. (2015) (0)
- Serotonin Receptor Imaging: Clinically Useful? (2012) (0)
- The Neurobiology of the Switch Process in Bipolar Disorder: A Review (2012) (0)
- Metacognition in Schizophrenia: Associations With Multiple Assessments of Executive Function (2009) (0)
- T85. THE EFFECT OF ADJUNCT ARIPIPRAZOLE ON MEASURES OF TOBACCO USE AND CRAVING IN WOMEN WITH PSYCHOTIC DISORDERS (2019) (0)
- 472. Functional magnetic resonance imaging and schizophrenia (1996) (0)
- The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited: Evidence of Genetic Moderation (2012) (0)
- FROM THE EDITOR'S PEN (2006) (0)
- Reduced Hippocampal Volumes Associated With the Long Variant of the Serotonin Transporter Polymorphism in Major DepressionFrodl T, Meisenzahl EM, Zill P, et al (Ludwig-Maximilians-Univ, Munich) Arch Gen Psychiatry 61:177–183, 2004§ (2006) (0)
- 726. Predicting Relapse in Schizophrenia: Is BDNF a Plausible Biological Marker? (2017) (0)
- Research and Practice in Substance Abuse Comorbidity (2005) (0)
- Fairbairn and the Origins of Object Relations. (1995) (0)
- Chapter 6 Schizophrenia as a brain disease (2008) (0)
- The Prefrontal Cortex: Insights From Functional Neuroimaging Using Cognitive Activation TasksGoethals I, Audenaert K, Van de Wiele C, et al (Ghent Univ, Belgium) Eur J Nucl Med Mol Imaging 31:408–416, 2004§ (2006) (0)
- Unresponsive and Mute after He Smoked 'Spice' (2016) (0)
- Clinical News. (2019) (0)
- Early Stages of Tardive Dyskinesia (2010) (0)
- Is It Treatment-Refractory Schizophrenia . . . And if It Is? (2011) (0)
- Violence and schizophrenia. (2013) (0)
- From the desk of Peter F. Buckley, MD. (2018) (0)
- Reduced density of calbindin-immunoreactive interneurons in the planum temporale in schizophreniaChance SA, Walker M; Crow TJ (Radcliffe Infirmary, Oxford, England; Warneford Hosp, Oxford; England) Brain Res 1046:32–37, 2005§ (2007) (0)
- 3-D surface analysis of the ventricular system in schizophrenia (1996) (0)
- Brain-derived neurotrophic factor and serotonin transporter gene-linked promoter region genes alter serum levels of brain-derived neurotrophic factor in humans (2012) (0)
- Early Intervention for Psychosis (2013) (0)
- Abstracts from the ASENT 2006 Annual Meeting March 8–11, 2006 (2006) (0)
- Circulating Aβ40 influences plasma BDNF levels and white matter integrity (2012) (0)
- 751 Electroencephalographic pattern, side-effect profile and clozapine plasma levels in patients receiving 900 mg of clozapine (1997) (0)
- Drug development update. (2015) (0)
- A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia (2009) (0)
- Abstracts from the ASENT 2005 Annual Meeting March 3–5, 2005 (2005) (0)
- BRAIN DERIVED NEUROTROPHIC FACTOR: ILLUSTRATIVE OF A PUTATIVE BIOMARKER FOR SCHIZOPHRENIA (2012) (0)
- 59. Expanding use of atypical antipsychotics (2000) (0)
- Clinical News. (2018) (0)
- Update on Psychiatric Genetics: Preparing the Way for Precision Medicine (2021) (0)
- Deep brain stimulation of the subcallosal cingulate gyrus for depression: anatomical location of active contacts in clinical responders and a suggested guideline for targeting (2011) (0)
- Schizophrenia: From brain morphology to psychopathology (2007) (0)
- Chapter 5 Aetiology (2008) (0)
- Clinical News. (2015) (0)
- History of substance abuse and response to clozapine treatment (1993) (0)
- Comprar Administrative Psychiatry, An Issue of Psychiatric Clinics | Peter F. Buckley | 9781416058694 | Saunders (2008) (0)
- Clinical News. (2018) (0)
- Clinical News (2010) (0)
- Genetic Studies of Drug Response and Side Effects in the STAR∗D Study, Part 1 (2011) (0)
- Chapter 8 Pharmacological and physical treatments (2008) (0)
- Neuroradiological anomalies and schizophrenia. (1993) (0)
- Dr. Buckley and Associates Reply (1980) (0)
- Neural correlates of the misattribution of speech in schizophreniaAllen P, Amaro E, Fu CHY, et al (Inst of Psychiatry, London) Br J Psychiatry 190:162–169, 2007§ (2008) (0)
- Assessment of Posttraumatic Symptoms in Patients With First-Episode Psychosis (2013) (0)
- Treatment non-responders: A neurobiological investigation (1995) (0)
- Effects of New Antipsychotics and Adjunctive Therapy for Schizophrenia (Video: 4:05 minutes) (2012) (0)
- Association of Plasma Interleukin-18 Levels with Emotion Regulation and μ-Opioid Neurotransmitter Function in Major Depression and Healthy Volunteers (2012) (0)
- Feigned psychosis - a case of factitious disorder (1991) (0)
- Acknowledgement to assessors (2010) (0)
- 459 Proton magnetic resonance spectroscopy and aberrant neurodevelopment: Frontallobe metabolism in adolescent-onset schizophrenia and in autism (1997) (0)
- A Randomized Trial of 2 Prescription Strategies for Opioid Treatment of Chronic Nonmalignant Pain (2012) (0)
- Treatment of schizophrenia: advances during the decade of the brain. (1996) (0)
- FROM THE EDITOR'S PEN (2008) (0)
- F190. Investigation of the Visual Steady-State Response and Cognition in Schizophrenia (2019) (0)
- Abnormal Glucose Metabolism in the Mediodorsal Nucleus of the Thalamus in SchizophreniaHazlett EA, Buchsbaum MS, Kemether E, et al (Mount Sinai School of Medicine, New York) Am J Psychiatry 161:305–314, 2004§ (2006) (0)
- Association between parental separation and cannabis use in first episode psychosis (2006) (0)
- Editor's Pen (2009) (0)
- Special clinical situations (2012) (0)
- A Tour de Force of the History of Psychiatry (2015) (0)
- Psychoanalytic pluralism and its vicissitudes. (1999) (0)
- Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective Disorder (2013) (0)
- CPNP 2019 Annual Meeting Poster Abstracts (2019) (0)
- Serotonin Transporter Gene Promoter Polymorphism and Somatoform Symptoms (2011) (0)
- Academic Health Centers as Healthy Learning Environments: “Form Follows Function” in Promoting Empathic Care (2019) (0)
- Progressive Brain Changes in Children and Adolescents With First-Episode Psychosis (2013) (0)
- 2011 Wayne Fenton Award for Exceptional Clinical Care The Wayne Fenton Award for Exceptional Clinical Care was established in 2007 to recognize clinical providers who exemplify Dr. Fenton's commitment to improving the daily lives of individuals with schizophrenia (2011) (0)
- Insight and aggression in schizophrenia. Authors' reply (2005) (0)
- Editor's Pen (2010) (0)
- Schizophrenia Pharmacotherapy: What Role for Perphenazine? (Video 1:39 minutes) (2012) (0)
- A Comprehensive Evaluation of Georgia's State Hospital Services (2007) (0)
- Research and Practice in Substance Abuse Comorbidity (2005) (0)
- Understanding Schizoaffective Disorder: From Psychobiology to Psychosocial Functioning (2012) (0)
- Regional Gray Matter Abnormalities in Obsessive-Compulsive Disorder: A Voxel-Based Morphometry StudyValente AA Jr, Miguel EC, Castro CC, et al (Univ of São Paulo, Brazil; Inst of Psychiatry, London) Biol Psychiatry 58:479–487, 2005§ (2007) (0)
- Mutability of Psychosis and Medications (2018) (0)
- Controlling Negative Symptoms in Schizophrenia (Video: 2:54 minutes) (2012) (0)
- Secondary Traumatic Stress in Attorneys and Their Administrative Support Staff Working With Trauma-exposed Clients (2013) (0)
- The widening intellectual scope of psychoanalysis. (1998) (0)
- Poster #T161 AN OPEN-LABEL TRIAL OF ADJUNCTIVE TOCILIZUMAB IN SCHIZOPHRENIA (2014) (0)
- S-56-3 Neurodevelopmental disturbance in schizophrenia as the origin of later, active disease? (1996) (0)
- Adaptation of Dialectical Behavior Therapy Skills Training Group for Treatment-Resistant Depression (2009) (0)
- The evidence for pharmacological treatment of neuropathic pain (2012) (0)
- M220. SELF-STIGMA, RESILIENCE, AND RECOVERY ATTITUDES AS PREDICTORS OF FUNCTIONING IN PEOPLE WITH SERIOUS MENTAL ILLNESSES (2020) (0)
- Clinical News (2008) (0)
- Glucocorticoid Effects on Object Recognition Memory Require Training-Associated Emotional ArousalOkuda S, Roozendaal B, McGaugh JL (Univ of California, Irvine; Banyu Pharmaceutical Co, Ltd, Tsukuba, Ibaraki, Japan) Proc Natl Acad Sci USA 101:853–858, 2004§ (2006) (0)
- Physical and psychosocial functioning following motor vehicle trauma: Relationships with chronic pain, posttraumatic stress, and medication use (2011) (0)
- Mental health in the medical setting: service delivery, workforce needs, and emerging best practices. (2015) (0)
- Proton Magnetic Resonance Spectroscopy Measurement of Brain Glutamate Levels in Premenstrual Dysphoric Disorder (2009) (0)
- A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder (2011) (0)
- Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthoodWeaver ICG, Meaney MJ, Szyf M (Douglas Hosp Research Ctr, Montréal; McGill Univ, Montréal) Proc Natl Acad Sci USA 103:3480–3485, 2006§ (2007) (0)
- FROM THE EDITOR'S PEN (2006) (0)
- Research and Practice in Substance Abuse Comorbidity: Making Progress (2006) (0)
- Meta-analysis of P31 MR spectroscopy studies in schizophrenia (1998) (0)
- Pharmacogenetics and Treatment- Resistant Schizophrenia 12 (2014) (0)
- A Diffusion Tensor Imaging Study of White Matter in Early-Onset Schizophrenia (2009) (0)
- Clinical Reports and Demonstrations: Section of Neurology: Cases Shown at the West End Hospital for Nervous Diseases, London, W.1, November 25, 1937: Familial Tremor (1938) (0)
- Opioid Formulations Designed to Resist/Deter Abuse (2012) (0)
- 61. Extracranial size in patients with schizophrenia (2000) (0)
- A Population Based Analysis of Subclinical Psychosis and Help-Seeking Behavior (2013) (0)
- Glycine and D-Cycloserine Attenuate Vacuous Chewing Movements in a Rat Model of Tardive DyskinesiaShoham S, Mazeh H, Javitt DC, et al (Ezrath Nashim-Herzog Mem Hosp, Jerusalem; New York Univ; Hebrew Univ, Jerusalem) Brain Res 1004:142–147, 2004§ (2006) (0)
- Epidemiology and longitudinal course (2012) (0)
- Violence and schizophrenia: Further observations on standards of care (2003) (0)
- Bromization: the truths we know about the psychopharmacology of schizophrenia. (2011) (0)
- Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry (2008) (0)
- Chapter 2 Clinical features (2008) (0)
- Research and Practice in Substance Abuse Comorbidity (2005) (0)
- Abstracts from the ASENT 2006 Annual Meeting March 8–11, 2006 (2006) (0)
- Sleep and circadian rhythm disruption in schizophrenia (2013) (0)
- Irish neurological association (1993) (0)
- Experiencing Psychosis: Personal and Professional Perspectives (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter Francis Buckley?
Peter Francis Buckley is affiliated with the following schools:
